17-14301093-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_006041.3(HS3ST3B1):c.-426T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 185,222 control chromosomes in the GnomAD database, including 5,346 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.23 ( 4320 hom., cov: 34)
Exomes 𝑓: 0.23 ( 1026 hom. )
Consequence
HS3ST3B1
NM_006041.3 5_prime_UTR
NM_006041.3 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.578
Publications
6 publications found
Genes affected
HS3ST3B1 (HGNC:5198): (heparan sulfate-glucosamine 3-sulfotransferase 3B1) The protein encoded by this gene is a type II integral membrane protein that belongs to the 3-O-sulfotransferases family. These proteins catalyze the addition of sulfate groups at the 3-OH position of glucosamine in heparan sulfate. The substrate specificity of individual members of the family is based on prior modification of the heparan sulfate chain, thus allowing different members of the family to generate binding sites for different proteins on the same heparan sulfate chain. Following treatment with a histone deacetylase inhibitor, expression of this gene is activated in a pancreatic cell line. The increased expression results in promotion of the epithelial-mesenchymal transition. In addition, the modification catalyzed by this protein allows herpes simplex virus membrane fusion and penetration. A very closely related homolog with an almost identical sulfotransferase domain maps less than 1 Mb away. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.4 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HS3ST3B1 | ENST00000360954.3 | c.-426T>C | 5_prime_UTR_variant | Exon 1 of 2 | 1 | NM_006041.3 | ENSP00000354213.2 | |||
| HS3ST3B1 | ENST00000466596.5 | n.-426T>C | non_coding_transcript_exon_variant | Exon 1 of 3 | 2 | ENSP00000436078.1 | ||||
| ENSG00000294706 | ENST00000725301.1 | n.13A>G | non_coding_transcript_exon_variant | Exon 1 of 1 | ||||||
| HS3ST3B1 | ENST00000466596.5 | n.-426T>C | 5_prime_UTR_variant | Exon 1 of 3 | 2 | ENSP00000436078.1 |
Frequencies
GnomAD3 genomes AF: 0.234 AC: 35558AN: 152146Hom.: 4323 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
35558
AN:
152146
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.234 AC: 7712AN: 32958Hom.: 1026 Cov.: 0 AF XY: 0.240 AC XY: 3983AN XY: 16576 show subpopulations
GnomAD4 exome
AF:
AC:
7712
AN:
32958
Hom.:
Cov.:
0
AF XY:
AC XY:
3983
AN XY:
16576
show subpopulations
African (AFR)
AF:
AC:
263
AN:
1110
American (AMR)
AF:
AC:
180
AN:
766
Ashkenazi Jewish (ASJ)
AF:
AC:
358
AN:
1250
East Asian (EAS)
AF:
AC:
576
AN:
1880
South Asian (SAS)
AF:
AC:
390
AN:
1194
European-Finnish (FIN)
AF:
AC:
208
AN:
1430
Middle Eastern (MID)
AF:
AC:
55
AN:
172
European-Non Finnish (NFE)
AF:
AC:
5163
AN:
22860
Other (OTH)
AF:
AC:
519
AN:
2296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
267
533
800
1066
1333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.234 AC: 35577AN: 152264Hom.: 4320 Cov.: 34 AF XY: 0.232 AC XY: 17303AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
35577
AN:
152264
Hom.:
Cov.:
34
AF XY:
AC XY:
17303
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
8533
AN:
41572
American (AMR)
AF:
AC:
3491
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1070
AN:
3472
East Asian (EAS)
AF:
AC:
1537
AN:
5156
South Asian (SAS)
AF:
AC:
2000
AN:
4822
European-Finnish (FIN)
AF:
AC:
1528
AN:
10610
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16420
AN:
68014
Other (OTH)
AF:
AC:
563
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1437
2874
4312
5749
7186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1260
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.